NuVasive (NUVA) Misses Q3 EPS by 6c, Revenues Beat; Lowers FY18 EPS View Below Consensus, Lifts FY18 Revenue Views Above Consensus

Go back to NuVasive (NUVA) Misses Q3 EPS by 6c, Revenues Beat; Lowers FY18 EPS View Below Consensus, Lifts FY18 Revenue Views Above Consensus

NuVasive Reports Third Quarter 2018 Financial Results

October 30, 2018 4:02 PM EDT

SAN DIEGO, Oct. 30, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced financial results for the quarter ended September 30, 2018. 

Third Quarter 2018 Highlights

Revenue increased 9.8% to $271.3 million, or 10.2% on a constant currency basis; GAAP operating profit margin of 6.6%; Non-GAAP operating profit margin of 15.6%; GAAP... More